Pets
“A 2026 prospective observational study published in the Journal of Veterinary Internal Medicine examining 743 Golden Retrievers found that dogs with digestive/gut problems had approximately 4x (289%) higher odds of having epilepsy/seizures than dogs without those symptoms." (Post image text: "NEW STUDY: DOGS WITH GUT PROBLEMS HAVE 4x…”
Plain restatementA 2026 study in the Journal of Veterinary Internal Medicine of 743 Golden Retrievers reported that dogs whose owners reported gastrointestinal signs had roughly four times the odds of having idiopathic epilepsy compared with dogs without such signs. A second claim states that a 2025 study in Research in Veterinary Science found that dogs with epilepsy given canine-derived Lactobacillus for three months had fewer seizures and fewer seizure days.
General information only - not veterinary advice.
The study behind this post is real and the number is close to right. A 2026 paper in the Journal of Veterinary Internal Medicine looked at 743 Golden Retrievers in Sweden and found that dogs whose owners reported digestive problems had about 3.9 times the odds of having idiopathic epilepsy, which is the "4x" and "289%" in the post. What the post leaves out matters: this was one breed in one country, the result shows two things occurring together and does not show that gut problems cause seizures, and it rests on only 29 dogs with epilepsy. Dogs with epilepsy are often on long-term seizure medication that can itself upset the stomach, and the available summary does not rule that out. The second study cited did report fewer seizures in epileptic dogs given specific canine-derived Lactobacillus strains over three months, but the authors themselves present this as something needing further study alongside conventional epilepsy treatment, and the strains in the product being advertised are not the strains that were tested. Published veterinary guidance treats epilepsy as a condition diagnosed and managed by a veterinarian with prescribed anticonvulsant medication, and the probiotic paper's own framing is as a possible addition to that treatment rather than a substitute for it. General information only, not veterinary advice.
A 2026 [drifted from the evidence:] prospective observational study [drifted from the evidence:] published in the Journal of Veterinary Internal Medicine [drifted from the evidence:] examining 743 Golden Retrievers [drifted from the evidence:] found that dogs [drifted from the evidence:] with digestive/gut problems had [drifted from the evidence:] approximately 4x (289%) higher odds of having [drifted from the evidence:] epilepsy/seizures than dogs without [drifted from the evidence:] those symptoms." (Post image text: "NEW STUDY: DOGS WITH GUT PROBLEMS HAVE 4x HIGHER ODDS OF HAVING SEIZURES. THE GUT & BRAIN COMMUNICATE THROUGH BIOLOGICAL PATHWAYS THAT INFLUENCE SEIZURES." Caption adds a second claim that a 2025 [drifted from the evidence:] probiotic study found fewer seizures, [drifted from the evidence:] followed by promotion of a probiotic product.)
A 2026 study in the Journal of Veterinary Internal Medicine [added by the neutral restatement:] of 743 Golden Retrievers [added by the neutral restatement:] reported that dogs [added by the neutral restatement:] whose owners reported gastrointestinal signs had [added by the neutral restatement:] roughly four times the odds of having [added by the neutral restatement:] idiopathic epilepsy compared with dogs without [added by the neutral restatement:] such signs. A second claim [added by the neutral restatement:] states that a 2025 study [added by the neutral restatement:] in Research in Veterinary Science found [added by the neutral restatement:] that dogs with epilepsy given canine-derived Lactobacillus for three months had fewer seizures [added by the neutral restatement:] and fewer seizure days.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- A 2026 study in the Journal of Veterinary Internal Medicine examining 743 Golden Retrievers exists, published 10 October 2026.
- In that study, dogs with reported gastrointestinal signs had about 3.9 times the odds of idiopathic epilepsy compared with dogs without those signs, which is close to the "approximately 4x" and "289% higher odds" in the post.
- The sample size, the journal and the breed in the post match the study.
- A 2025 peer-reviewed paper in Research in Veterinary Science did report that three months of canine-derived Lactobacillaceae supplementation was associated with lower seizure frequency in dogs with idiopathic epilepsy.
- The caption's statement that researchers suggest probiotics deserve further investigation as an addition to conventional epilepsy treatment reflects how that paper frames its own result.
- The image headline says "DOGS WITH GUT PROBLEMS HAVE 4x HIGHER ODDS OF HAVING SEIZURES". The figure comes from Golden Retrievers in Sweden, a single breed in a single country. Whether the same ratio holds in other breeds was not tested by this study.
- The outcome in the study is a diagnosis of idiopathic epilepsy. The post widens it to "seizures", which covers many causes that the study did not measure.
- The post states the gut and brain "communicate through biological pathways that influence seizures" directly beneath the study figure. The study reports that two things occur together more often than expected. It does not show which came first, nor that gut changes produce seizures. Dogs with epilepsy are commonly on long-term anticonvulsant medication, which itself can produce digestive signs, and that alternative explanation is not addressed in the material available.
- The caption moves from an association finding to a specific product for sale. The product's strains are not the canine-derived Lactobacillaceae strains used in the 2025 study, so the study result does not transfer to the product being promoted.
- "Evidence-backed strains" describes strains studied for digestive or stress endpoints, not for seizure control. Placing them under a seizure headline implies a seizure benefit that the cited evidence does not establish for them.
- The 289 percent figure is presented as a precise result. The underlying estimate rests on 29 affected dogs, and no confidence interval is given anywhere in the post.
- Whether the study's own design label is "prospective observational" as the post states. The retrieved description, a prevalence figure plus a comparison of 29 affected and 714 unaffected dogs, is consistent with a cross-sectional or questionnaire-based design, and the paper's wording was not read.
- Whether the 3.9 odds ratio was adjusted for age, sex, medication use or other conditions, and how wide its confidence interval is.
- How gastrointestinal signs were defined and ascertained, and whether they were recorded before or after the epilepsy diagnosis.
- Whether the 2025 probiotic study included a control group, blinding or randomisation, and how many dogs it followed.
- Funding and declared interests for either study.
A real 2026 Journal of Veterinary Internal Medicine paper on Golden Retrievers exists and matches the headline numbers. The trade summary of it states the study examined 743 Golden Retrievers in Sweden, of which 29 were diagnosed with idiopathic epilepsy and 714 were unaffected, that nearly 4 percent of the dogs had idiopathic epilepsy, that almost half of the affected dogs had cluster seizures, and that Golden Retrievers with reported gastrointestinal signs had approximately 3.9 times the odds of idiopathic epilepsy compared with dogs without those problems. The 3.9 figure corresponds to about 290 percent higher odds, which matches the post's "289%" within rounding. The study is an association study in one breed in one country. Nothing in the retrieved material reports that gastrointestinal problems were shown to cause seizures, that the direction of the relationship was established, or that gut-directed treatment changed seizure outcomes. Odds ratios in the summary are not accompanied by confidence intervals, and with 29 epilepsy cases the estimate rests on a small number of affected dogs. The second cited paper is also real. García-Belenguer and colleagues, Research in Veterinary Science, 2025, supplemented dogs with idiopathic epilepsy with canine-derived Lactobacillaceae strains for three months and reported that supplementation was associated with lower seizure frequency in drug-sensitive and drug-refractory epilepsy. The paper's own highlights state that the improvement was not associated with an increase in gut Lactobacillus or in plasma GABA, and that although some changes in gut microbiota were observed, blood neurotransmitters remained unchanged. The authors frame probiotics as warranting further investigation alongside conventional treatment, not as a replacement for it.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.